The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-(2,4-dichlorophenoxy)-N-(3-methyl-1-(tetrahydro-2H-pyran-4-yl)-1H-pyrazol-5-yl)acetamide ID: ALA5206362
Chembl Id: CHEMBL5206362
PubChem CID: 168296247
Max Phase: Preclinical
Molecular Formula: C17H19Cl2N3O3
Molecular Weight: 384.26
Associated Items:
Names and Identifiers Canonical SMILES: Cc1cc(NC(=O)COc2ccc(Cl)cc2Cl)n(C2CCOCC2)n1
Standard InChI: InChI=1S/C17H19Cl2N3O3/c1-11-8-16(22(21-11)13-4-6-24-7-5-13)20-17(23)10-25-15-3-2-12(18)9-14(15)19/h2-3,8-9,13H,4-7,10H2,1H3,(H,20,23)
Standard InChI Key: LAFBYWFEZKXFIX-UHFFFAOYSA-N
Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 384.26Molecular Weight (Monoisotopic): 383.0803AlogP: 3.87#Rotatable Bonds: 5Polar Surface Area: 65.38Molecular Species: NEUTRALHBA: 5HBD: 1#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 12.27CX Basic pKa: 2.76CX LogP: 2.55CX LogD: 2.55Aromatic Rings: 2Heavy Atoms: 25QED Weighted: 0.85Np Likeness Score: -2.24
References 1. Sharma S, Lesiak L, Aretz CD, Du Y, Kumar S, Gautam N, Alnouti Y, Dhuria NV, Chhonker YS, Weaver CD, Hopkins CR.. (2021) Discovery, synthesis and biological characterization of a series of N -(1-(1,1-dioxidotetrahydrothiophen-3-yl)-3-methyl-1H -pyrazol-5-yl)acetamide ethers as novel GIRK1/2 potassium channel activators., 12 (8.0): [PMID:34458739 ] [10.1039/D1MD00129A ]